New hope for Tough-to-Treat colon cancer: experimental drug combo enters final testing
NCT ID NCT07549412
First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times
Summary
This Phase 3 trial tests a new drug called precemtabart tocentecan, alone or with bevacizumab, against a standard treatment for metastatic colorectal cancer that has progressed after prior therapies. About 1,020 participants will be randomly assigned to one of three treatment groups. The main goal is to see if the new drug helps people live longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- precemtabart tocentecan (a drug), bevacizumab, and trifluridine/tipiracil
- What this could lead to
- If successful, this could offer a new treatment option for people with metastatic colorectal cancer who have already tried standard therapies, potentially extending survival.
- What could go wrong
- This is a large Phase 3 trial, but the experimental drug is still unproven. It may not improve survival or could cause side effects. Results may take years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Blue Ridge Cancer Care - 300202915
RECRUITINGRoanoke, Virginia, 24014-2419, United States
-
Cancer Institute Hospital of JFCR
RECRUITINGKōtoku, Tokyo-To, 135-8550, Japan
-
China Medical University Hospital
RECRUITINGTaichung, 40447, Taiwan
-
Flinders Medical Centre
RECRUITINGBedford Park, South Australia, 5042, Australia
-
Florida Cancer Specialists - St. Petersburg Bayfront
RECRUITINGSt. Petersburg, Florida, 33701-4553, United States
-
Florida Cancer Specialists East - FCS EAST - West Palm Beach
RECRUITINGWest Palm Beach, Florida, 33401, United States
-
Florida Cancer Specialists-Broadway
RECRUITINGFort Myers, Florida, 33901, United States
-
GenesisCare North Shore (Oncology)
RECRUITINGSt Leonards, New South Wales, 2065, Australia
-
Icon Cancer Centre Chermside
RECRUITINGChermside, Queensland, 4032, Australia
-
Illinois Cancer Specialists
RECRUITINGArlington Heights, Illinois, 60005, United States
-
Illinois CancerCare PC
RECRUITINGPeoria, Illinois, 61615-7822, United States
-
Kanagawa Cancer Center - Dept of Gastroenterology
RECRUITINGYokohama, Kanagawa, 241-8515, Japan
-
Kindai University Hospital
RECRUITINGSakai-shi, Osaka, 590-0197, Japan
-
Kyungpook National University Chilgok Hospital
RECRUITINGDaegu, Gyeongsangnam-do, 700-721, South Korea
-
Mater Misericordiae Ltd - PARENT
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
-
Minnesota Oncology Hematology, P.A.
RECRUITINGSaint Louis Park, Minnesota, 55416, United States
-
Missouri Cancer Associates - 150518964
RECRUITINGColumbia, Missouri, 65201, United States
-
National Cancer Center Hospital
RECRUITINGChūōku, Tokyo-To, 104-0045, Japan
-
Profound Research LLC at Cancer and Leukemia Center
RECRUITINGSterling Heights, Michigan, 48098, United States
-
Rocky Mountain Cancer Centers, LLP- Aurora
RECRUITINGLone Tree, Colorado, 80124, United States
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Severance Hospital, Yonsei University Health System - Division of Infectious Diseases
RECRUITINGSeoul, 03722, South Korea
-
Sichuan Cancer Hospital
RECRUITINGChengdu, Sichuan, 610041, China
-
Springfield Clinic
RECRUITINGSpringfield, Illinois, 62702, United States
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
Texas Oncology DFW
RECRUITINGBedford, Texas, 75246, United States
-
Texas Oncology, P.A. - Abilene - 300210366
RECRUITINGAbilene, Texas, 79606, United States
-
Texas Oncology, P.A. - Tyler
RECRUITINGTyler, Texas, 75702, United States
-
Texas Oncology- San Antonio
RECRUITINGSan Antonio, Texas, 78240, United States
-
Texas Oncology-South Austin
RECRUITINGAustin, Texas, 78745, United States
-
The Catholic University of Korea, Seoul St. Maryâ
RECRUITINGSeoul, 06591, South Korea
-
University Health Network - Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Virginia Oncology Associates
RECRUITINGNewport News, Virginia, 23606, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can delivering cancer drug directly to the liver shrink tumors?
- Blood biomarkers could replace invasive biopsies for colorectal cancer monitoring
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Can a Two-Drug combo outsmart resistant colorectal cancer?
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- Can a Triple-Drug rechallenge tame colorectal cancer?